AG1 vs Apple Watch
Side-by-side comparison of AI visibility scores, market position, and capabilities
Single-SKU greens supplement brand projecting $600M revenue in 2025 at $1.2B valuation; built almost entirely on DTC subscriptions with no retail distribution; endorsed by Andrew Huberman and powered by word-of-mouth among health-conscious consumers.
About
AG1 (formerly Athletic Greens) is a New Zealand-founded, US-focused nutritional supplement company that manufactures a single flagship product: a daily all-in-one greens powder. Founded in 2010 and now headquartered in Las Vegas, the company bootstrapped to approximately $160 million in revenue before raising $115 million in a growth round in January 2022 at a $1.2 billion valuation, led by Alpha Wave Global.\n\nAG1 projects revenue of approximately $600 million in 2025, driven almost entirely by direct-to-consumer subscriptions sold online. The company has no retail distribution and no SKU diversification — an unusual strategy that has proven powerful for brand clarity and margin preservation. AG1 products are endorsed by high-profile athletes and health podcasters including Andrew Huberman, fueling viral word-of-mouth and podcast advertising at scale.\n\nIn 2025 the company began expanding into complementary product lines while retaining its minimalist brand identity. Its subscription model creates strong LTV economics, and the company has been reportedly cash-flow positive since well before its funding round. AG1 is often cited as a benchmark for DTC supplement brand building.
Apple Watch, $18B+ revenue 2024, 22% global smartwatch market share, 34% US wearables market, 100M+ active users, Series 10 (2024): sleep apnea detection, blood oxygen, ECG, fall detection, watchOS 11, fitness tracking leader
About
Apple Watch was introduced in 2015 as Apple's entry into personal computing worn on the wrist, designed to extend the iPhone experience to the body and provide health and fitness intelligence unavailable from any other consumer device. Apple's mission for the product evolved rapidly from notification delivery to health monitoring, driven by the recognition that continuous, passive measurement of physiological signals could provide clinically meaningful insights at population scale. Its core technology integrates custom Apple silicon, optical heart rate sensors, an electrical heart sensor for ECG, a blood oxygen sensor, and accelerometers within an ultra-compact, water-resistant enclosure running watchOS.\n\nApple Watch Series 10 (2024) introduced sleep apnea detection — a first for any consumer wearable — joining an existing health feature set that includes ECG, irregular heart rhythm notifications, blood oxygen monitoring, crash detection, and fall detection. The Apple Watch platform connects tightly with the Health app and iPhone ecosystem, with third-party app integrations across fitness, medication tracking, mental health, and chronic disease management. Apple Watch serves a broad customer base from fitness-focused consumers to patients with prescribed monitoring needs, supported by FDA clearances on its core health features.\n\nApple Watch generated an estimated $18 billion or more in revenue in 2024, capturing approximately 22% of global smartwatch market share and 34% of the US wearables market, with more than 100 million active users globally. It competes with Samsung Galaxy Watch and Garmin but has no peer in terms of health feature depth, ecosystem integration, and installed base. As regulatory bodies and health systems increasingly recognize wearable-derived data as clinically actionable, Apple Watch's combination of consumer scale and health credibility positions it as the de facto platform for digital health at the consumer level.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.